Management of Leukocytosis and Thrombocytosis in Patients on Obesity Medication with Acne Flare

Laboratory Monitoring and Management

The American Academy of Dermatology recommends that laboratory monitoring for patients on isotretinoin should include liver function tests, fasting lipid panel, and pregnancy testing, but should not include complete blood count monitoring 1
The 2024 AAD guidelines state that isotretinoin causes mild, reversible decreases in WBC and neutrophils, with a 24% decrease in WBC and 33% decrease in neutrophils in good responders 1
Data from cohort studies estimate the risk of abnormal platelet levels at 1.2% to 2.9% and abnormal WBC count at 7.0% to 10.8% during isotretinoin therapy, but these changes remain within normal range 1

The American Academy of Dermatology recommends topical retinoid (adapalene 0.1-0.3% or tretinoin 0.025-0.1%) combined with benzoyl peroxide 2.5-5% for moderate acne flare, with addition of topical antibiotic (clindamycin 1% or erythromycin 3%) in fixed-dose combination with benzoyl peroxide if needed 3
For moderate-to-severe inflammatory acne, oral antibiotics (doxycycline 100 mg daily or minocycline 50-100 mg daily) should be added to topical retinoid plus benzoyl peroxide, with treatment limited to 3-4 months maximum to prevent bacterial resistance 3
Never use topical or oral antibiotics as monotherapy, as resistance develops rapidly without concurrent benzoyl peroxide 4

Isotretinoin is indicated for severe acne, treatment-resistant moderate acne after 3-4 months of appropriate therapy, or any acne with scarring or significant psychosocial burden 1
Standard isotretinoin dosing is 0.5 mg/kg/day for the first month, then increased to 1.0 mg/kg/day thereafter, targeting cumulative dose of 120-150 mg/kg 1
Required monitoring includes only liver function tests, fasting lipid panel, and pregnancy testing for patients with pregnancy potential—not CBC 1

Review the specific obesity medication for known hematologic effects, though these are uncommon 2
Continue obesity medication unless there is clear evidence of medication-induced hematologic toxicity, which is not present in this case 2